Healthcare Innovation April 4, 2024
Pietje Kobus

HHS publishes a white paper on policy considerations to address drug shortages

In an April 2 press release, the U.S. Department of Health and Human Services (HHS) announced the release of a white paper titled Policy Considerations to Prevent Drug Shortages and Mitigate Supply Chain Vulnerabilities in the United States. The paper outlines steps HHS has taken to prevent drug shortages. Additionally, the paper highlights solutions for policymakers.

“Hospitals can spend at least $600 million per year managing shortages,” the white paper reads. Shortages of life-saving drugs are a concern for patient care, health, and safety. According to HHS, there has been a shortage of 123 drugs as of January.

A new coordinator role has been established to help HHS...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, HHS, Pharma, Pharma / Biotech
Dr. Oz, RFK Jr. on Medicare, Medicaid: 10 notes
RFK Jr. eyes overhaul of Medicare physician pay: What to know
Reading RFK Jr.’s tea leaves
New HHS leader could overhaul Medicare physician reimbursement: reports
Docs deem RFK Jr. a ‘damaging’ and ‘devastating’ pick for HHS Secretary, but some see a silver lining

Share This Article